ストックスクリーナーアプリを入手
7.42
5.36%
-0.42
Rapt Therapeutics Inc (RAPT) 最新ニュース
Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Yahoo Finance
RAPT Therapeutics Executes 1-for-8 Reverse Stock Split - TipRanks
RAPT Therapeutics (RAPT) Trading Halted as News Awaits Release | RAPT Stock News - GuruFocus
Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Yahoo Finance
# RAPT Therapeutics to implement 1-for-8 reverse stock split By Investing.com - Investing.com South Africa
RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq
RAPT Therapeutics Shares to Start Trading on a Split-Adjusted Basis Tuesday - marketscreener.com
RAPT Therapeutics Announces Effective Date For 1-For-8 Reverse Stock Split - MarketScreener
RAPT Therapeutics Announces Reverse Stock Split Effective June 2025 | RAPT Stock News - GuruFocus
# RAPT Therapeutics to implement 1-for-8 reverse stock split - Investing.com
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewswire
RAPT Therapeutics Announces Major Share Consolidation: 132M Shares Shrinking to 16.5M in Reverse Split - Stock Titan
Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
Transcript : RAPT Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - MarketScreener
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position - MSN
RAPT Therapeutics Announces Development Plans for RPT904 - TipRanks
Jane Street Group LLC Sells 29,821 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
Nuveen Asset Management LLC Buys 39,216 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
RAPT Therapeutics (RAPT) Has a New Rating from Clear Street - The Globe and Mail
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position By Stocktwits - Investing.com India
Clear Street initiates Rapt Therapeutics stock with buy rating By Investing.com - Investing.com UK
Clear Street Initiates Coverage on Rapt Therapeutics (RAPT) with Buy Rating | RAPT Stock News - GuruFocus
Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
RAPT Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
RAPT Therapeutics Management to Share Latest Immunology Pipeline Updates at Major Healthcare Conferences - Stock Titan
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
RAPT Therapeutics Faces Nasdaq Delisting Notice - TipRanks
What is HC Wainwright’s Forecast for RAPT Q2 Earnings? - Defense World
UBS Group Cuts RAPT Therapeutics (NASDAQ:RAPT) Price Target to $1.00 - Defense World
RAPT Therapeutics (NASDAQ:RAPT) Stock Rating Upgraded by HC Wainwright - Defense World
D. E. Shaw & Co. Inc. Sells 278,173 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
RAPT Stock: HC Wainwright & Co. Announces New Price Target | RAP - GuruFocus
UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Stock News - GuruFocus
RAPT Analyst Update: UBS Adjusts Price Target to $1 | RAPT Stock News - GuruFocus
Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outl - GuruFocus
UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Sto - GuruFocus
Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outlook | RAPT Stock News - GuruFocus
UBS cuts Rapt Therapeutics stock target to $1 from $2 By Investing.com - Investing.com UK
Comerica Bank Purchases Shares of 58,040 RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
Dimensional Fund Advisors LP Sells 105,231 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World
RAPT Therapeutics Reports Improved Q1 2025 Results - TipRanks
RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire
RAPT Therapeutics, Inc. SEC 10-Q Report - TradingView
RAPT Therapeutics Reports Third Quarter 2024 Financial Results - ADVFN
RAPT Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
RAPTRapt Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Renaissance Technologies LLC Has $584,000 Stock Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World
2.13%
1.01%
大文字化:
|
ボリューム (24 時間):